Details of the Drug Formulaction | DrugMAP

General Information of Drug Formulation (ID: F05357)

Formulation Name

Desipramine 25 mg tablet

Company

Actavis Pharma

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Desipramine	DMT2FDC	Attention deficit hyperactivity disorder	6A05.Z	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	E00625	Not Available	Disintegrant
FD&C blue no. 1	E00263	19700	Colorant
Lactose monohydrate	E00393	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	E00208	11177	lubricant
Polysorbate 80	E00665	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Povidone	E00667	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Sodium lauryl sulfate	E00464	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide	E00322	26042	Coating agent; Colorant; Opacifying agent

--------------------